Stay updated on Foralumab Safety in NASH and T2DM Clinical Trial
Sign up to get notified when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.

Latest updates to the Foralumab Safety in NASH and T2DM Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov footer now identifies the site revision as v3.8.0 instead of v3.7.2.SummaryDifference0.1%

- Check26 days agoChange DetectedA notice about NIH’s terminology transition appears at the top of the page, and the site revision label changes from v3.7.1 to v3.7.2.SummaryDifference1.0%

- Check40 days agoChange DetectedThe ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check61 days agoChange DetectedThe record history adds a new revision entry for v3.7.0. The previous revision entry v3.6.6 is removed.SummaryDifference0.1%

- Check75 days agoChange DetectedA new revision entry, v3.6.6, was added to the study record history. The previous revision entry v3.6.5 was removed.SummaryDifference0.1%

- Check97 days agoChange DetectedAn additional revision entry, v3.6.5, has been added to the study's history, updating the version list. This change reflects an update to the record's metadata rather than substantive study content.SummaryDifference0.1%

Stay in the know with updates to Foralumab Safety in NASH and T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Foralumab Safety in NASH and T2DM Clinical Trial page.